Skip to content

Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery

Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02291939
Enrollment
5
Registered
2014-11-17
Start date
2015-01-31
Completion date
2015-12-31
Last updated
2016-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parotid Diseases

Brief summary

The objective of the clinical trial is to determine the suitability of the FMwand Ferromagnetic Surgical System for parotidectomy and Head & Neck surgery.

Interventions

PROCEDUREParotidectomy

Surgical Intervention with the FMwand Surgical System

Sponsors

Domain Surgical, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with an indication for surgical intervention for a parotidectomy. * ECOG status ≤ 2. * Life expectancy \> 3 months. * Age ≥ 18 years old. * Able to provide written informed consent and EU Data Protection Directive forms prior to admission to this study. * Willingness to meet all of the expected requirements of this clinical protocol.

Exclusion criteria

* Age \< 18 years old. * Pregnant or breastfeeding. * Vulnerable patient populations (homeless patients, patients with drug or alcohol dependence, etc.). * Concomitant treatments that would affect clotting, post-operative healing, increased chances of infection. * Previous radiation treatment * Previous head or neck surgery

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative Serious Adverse Events as a Measure of Safety and Feasibility1 day after surgerySafety and feasibility will be assessed by evaluating intra-operative serious adverse events, if any, and their relationship with the FMwand Ferromagnetic Surgical System.

Secondary

MeasureTime frameDescription
Post-operative drainiageBeginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 daysEvaluation of Post-operative Drainage
Swelling of surgical woundBeginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 daysEvaluation of surgical wound appearance based on swelling
Necrosis of surgical marginsBeginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 daysSerosity and necrosis of margins
Length of hospital stayBeginning day 2 after surgery and for the duration of hospital stay, an expected average of 6 daysNumber of days (post-operative) of hospital stay

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026